Drug Topics August 2, 2024
Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.
Pharmacists’ ability to administer oral anticoagulation (OAC) therapy highlights a significantly effective opportunity to close gaps in the delivery of prescriptions to treat the reduction of stroke risk in patients with actionable atrial fibrillation (AF). With no increase in adverse events or the use of health care services, the next step in pharmacists’ ability to deliver OAC prescriptions is measuring the scalability and sustainability in future studies, according to authors of a study published in JAMA Network Open.1
One of the leading causes of stroke in older adults and the most common heart rhythm...
Today's Sponsors
Today's Sponsor